EvoRadar
Pricing
AI BrainIdeasDice
2367 ideas0 HOT538 WARM1829 COLD
© 2026 Kisum GmbH·ImpressumDatenschutzSubprocessorsAGBVerträge hier kündigen·GitHub
EvoRadar — AI-Discovered Startup Opportunitiesevoradar.ai
© 2026 Kisum GmbHevoradar.ai · Generated by EvoRadar
← BackWatch AI Discovery

Cosmetics Ingredient Computational Safety Pre-Screening

COLD✧ v8Cosmetics / Regulatory ScienceWestern Europe16 Mar 2026

One-Liner

A computational pre-screening platform for new cosmetics ingredients against EU Cosmetics Regulation 1223/2009 safety endpoints, replacing or reducing the need for costly in vitro testing.

AI Thinking Process

Impossibility Negation engine: 'You can't computationally pre-screen new cosmetics ingredients for safety at regulatory speed.' DrugCLIP million-fold screening capability applied to cosmetics — animal testing ban since 2013 creates institutional pressure for computational alternatives.

Thread 1: Cosmetics Ingredient Computational Safety Pre-Screening. EU Cosmetics Regulation 1223/2009 bans 1,600+ substances. Current method: in vitro testing, 6-18 months, $30-80K per ingredient. Target: indie cosmetics ingredient suppliers.

General QSAR tools: OECD QSAR Toolbox, ProtoQSAR, Intertek, Lhasa Limited (Derek Nexus). None cosmetics-specific with EU Cosmetics Regulation endpoints. Inter-industry gap: computational chemistry × cosmetics regulatory compliance. Neither side owns the cosmetics-specific computational pre-screening space.

SURVIVED Pass 1 at 40% conviction. Biggest worry: regulatory acceptance timeline (will SCCS accept computational results as primary pre-screening evidence?).

KILLED — Historical duplicate of Cosmetic Ingredient Cell Safety Screener (). Same domain, same regulatory driver, same computational screening approach. Thread 18 extended exploration added formulation interaction screening as differentiator but core concept is identical. Explored twice before. Do not deepen.

Kill Reason

Historical duplicate of Cosmetic Ingredient Cell Safety Screener (a prior session) — same domain, same regulatory driver (EU animal testing ban, EC 1223/2009), same approach (computational screening as alternative to wet lab testing). The extended exploration added formulation-level interaction screening as a differentiator, but the core concept is identical to the idea. Also adjacent to Computational Safety Screening for Novel Food Ingredients from a prior crossdomain session.

Risk Analysis

Risk analysis available for latest engine ideas.

What do you think?

Related ideas you can explore free:

COLDMulti-Chip AI Orchestration Platform

killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.

COLDGPU Compute Brokerage

killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.

COLDEU AI Act Compliance Platform

killed: Template epidemic (G003) + industry-pain-form death pattern (G005) fire simultaneously. 13+ existing compliance tools. A prompt could do 80% of this.